Pharmaceutical Preparations
Standard Industrial Classification: SIC 2834
Industry Insider Sentiment Analysis
The Pharmaceutical Preparations sector (SIC 2834) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-19 01:12 | 2026-05-18 | ZBIO | Zenas BioPharma, Inc. | MOULDER LEON O JR | Director, Officer | BUY | $16.88 | 60,000 | $1,012,800 | 96,928 |
| 2026-05-19 00:32 | 2026-05-15 | MIRM | Mirum Pharmaceuticals, Inc. | Ramasastry Saira | Director | OPT+S | $109.47 | 2,000 | $218,940 | 0 |
| 2026-05-18 22:41 | 2026-05-18 | RARE | Ultragenyx Pharmaceutical Inc. | SULIMAN SHEHNAAZ | Director | SELL | $25.12 | 5,740 | $144,189 | 27,951 |
| 2026-05-18 22:07 | 2026-05-18 | ORKA | Oruka Therapeutics, Inc. | Agarwal Arjun | Officer | OPT+S | $59.07 | 10,290 | $607,807 | 16,406 |
| 2026-05-18 22:18 | 2026-05-15 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Director, Officer | OPT+S | $568.11 | 9,500 | $5,397,077 | 40,513 |
| 2026-05-18 21:36 | 2026-05-18 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Soergel David | Officer | SELL | $515.90 | 844 | $435,420 | 11,075 |
| 2026-05-18 20:00 | 2026-05-14 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Kalif Eliyahu Sharon | Officer | SELL | $35.61 | 153,251 | $5,457,375 | 172,184 |
| 2026-05-18 20:01 | 2026-05-14 | GYRE | GYRE THERAPEUTICS, INC. | Ye Weiguo | Officer | OPT+S | $6.79 | 28,680 | $194,772 | 700,000 |
| 2026-05-18 20:02 | 2026-05-14 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Lippman Evan | Officer | OPT+S | $35.58 | 41,658 | $1,482,367 | 44,191 |
| 2026-05-18 18:03 | 2026-05-15 | AQST | Aquestive Therapeutics, Inc. | Barber Daniel | Officer | SELL | $4.29 | 8,257 | $35,413 | 660,574 |
| 2026-05-18 16:09 | 2026-05-14 | ABCL | AbCellera Biologics Inc. | Montalbano John S. | Director | BUY | $4.77 | 20,000 | $95,400 | 241,000 |
| 2026-05-18 12:00 | 2026-05-14 | KYNB | KYNTRA BIO, INC. | Wettig Thane | Director, Officer | BUY | $7.09 | 2,800 | $19,852 | 27,203 |
| 2026-05-15 20:08 | 2026-05-14 | KPTI | Karyopharm Therapeutics Inc. | Poulton Stuart | Officer | SELL | $9.50 | 403 | $3,829 | 94,821 |
| 2026-05-15 20:07 | 2026-05-14 | KPTI | Karyopharm Therapeutics Inc. | Rangwala Reshma | Officer | SELL | $9.50 | 408 | $3,876 | 56,829 |
| 2026-05-15 20:05 | 2026-05-14 | KPTI | Karyopharm Therapeutics Inc. | Cheng Sohanya Roshan | Officer | SELL | $9.50 | 324 | $3,078 | 107,940 |
| 2026-05-15 20:04 | 2026-05-14 | KPTI | Karyopharm Therapeutics Inc. | Abate Kristin | Officer | SELL | $9.50 | 53 | $504 | 23,801 |
| 2026-05-15 20:03 | 2026-05-14 | KPTI | Karyopharm Therapeutics Inc. | Paulson Richard A. | Director, Officer | SELL | $9.50 | 2,203 | $20,929 | 269,747 |
| 2026-05-15 20:02 | 2026-05-14 | KPTI | Karyopharm Therapeutics Inc. | Mano Michael | Officer | SELL | $9.50 | 266 | $2,527 | 94,398 |
| 2026-05-15 20:37 | 2026-05-14 | RPRX | Royalty Pharma plc | Norden Gregory | Director | SELL | $53.00 | 3,045 | $161,385 | 191,803 |
| 2026-05-15 20:05 | 2026-05-13 | COLL | COLLEGIUM PHARMACEUTICAL, INC | Lurker Nancy | Director | SELL | $35.97 | 4,500 | $161,861 | 18,017 |
| 2026-05-15 20:07 | 2026-05-13 | INSM | INSMED Inc | Smith Michael Alexander | Officer | SELL | $116.18 | 4,109 | $477,384 | 47,762 |
| 2026-05-15 20:07 | 2026-05-13 | INSM | INSMED Inc | Flammer Martina M.D. | Officer | SELL | $116.12 | 18,333 | $2,128,892 | 64,910 |
| 2026-05-15 20:07 | 2026-05-13 | INSM | INSMED Inc | Adsett Roger | Officer | SELL | $116.18 | 5,837 | $678,143 | 100,973 |
| 2026-05-15 20:08 | 2026-05-13 | INSM | INSMED Inc | Bonstein Sara | Officer | SELL | $116.18 | 8,272 | $961,041 | 71,486 |
| 2026-05-15 20:06 | 2026-05-13 | INSM | INSMED Inc | Lewis William | Director, Officer | SELL | $116.18 | 13,283 | $1,543,219 | 287,902 |
| 2026-05-15 20:24 | 2026-04-02 | SNSE | Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC | 10% owner | SELL | $31.51 | 17,076 | $538,114 | 133,986 |
| 2026-05-15 20:24 | 2026-04-02 | SNSE | Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC | 10% owner | BUY | $33.54 | 4,215 | $141,364 | 133,986 |
| 2026-05-15 20:22 | 2026-03-31 | SNSE | Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC | 10% owner | SELL | $28.07 | 2,741 | $76,949 | 147,731 |
| 2026-05-15 20:22 | 2026-03-31 | SNSE | Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC | 10% owner | BUY | $31.37 | 12,180 | $382,100 | 147,731 |
| 2026-05-15 20:22 | 2026-03-26 | SNSE | Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC | 10% owner | SELL | $27.50 | 3,250 | $89,390 | 145,678 |
| 2026-05-15 20:22 | 2026-03-26 | SNSE | Sensei Biotherapeutics, Inc. | MILLENNIUM MANAGEMENT LLC | 10% owner | BUY | $26.75 | 30,585 | $818,256 | 145,678 |
| 2026-05-16 00:49 | 2026-05-13 | RLYB | Rallybio Corp | ADAR1 Capital Management, LLC | 10% owner | BUY | $13.99 | 79,559 | $1,112,975 | 910,143 |
| 2026-05-16 00:17 | 2026-05-15 | ORKA | Oruka Therapeutics, Inc. | Goncalves Joana | Officer | OPT+S | $61.85 | 7,000 | $432,935 | 33,377 |
| 2026-05-15 22:59 | 2026-05-13 | LQDA | Liquidia Corp | JEFFS ROGER | Director, Officer | SELL | $57.32 | 75,000 | $4,298,768 | 1,198,095 |
| 2026-05-15 22:15 | 2026-05-13 | IONS | IONIS PHARMACEUTICALS INC | Monia Brett P | Director, Officer | OPT+S | $78.49 | 4,536 | $356,012 | 242,662 |
| 2026-05-15 21:20 | 2026-05-14 | PTCT | PTC THERAPEUTICS, INC. | Klein Matthew B. | Director, Officer | SELL | $72.95 | 12,572 | $917,154 | 393,998 |
| 2026-05-15 21:04 | 2026-05-14 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Director, Officer | OPT+S | $574.48 | 9,500 | $5,457,566 | 40,513 |
| 2026-05-15 21:00 | 2026-05-15 | ABEO | ABEONA THERAPEUTICS INC. | Crombez Eric | Director | SELL | $5.53 | 26,143 | $144,636 | 37,313 |
| 2026-05-15 21:04 | 2026-05-14 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | Officer | OPT+S | $574.47 | 10,000 | $5,744,746 | 18,876 |
| 2026-05-15 20:38 | 2026-05-14 | RPRX | Royalty Pharma plc | Urist Marshall | Officer | SELL | $53.06 | 13,684 | $726,137 | 31,881 |
| 2026-05-15 20:39 | 2026-05-13 | ONC | BeOne Medicines Ltd. | Lee Chan Henry | Officer | OPT+S | $310.72 | 332 | $103,159 | 0 |
| 2026-05-15 20:45 | 2026-05-13 | ZLAB | Zai Lab Ltd | Du Ying | Director, Officer | OPT+S | $20.03 | 100,000 | $2,003,040 | 1,122,626 |
| 2026-05-15 20:46 | 2026-05-14 | ZLAB | Zai Lab Ltd | Edmondson Frazor Titus III | Officer | SELL | $20.19 | 3,517 | $71,008 | 19,849 |
| 2026-05-15 11:00 | 2026-05-14 | HROW | HARROW, INC. | BOLL ANDREW R. | Officer | BUY | $29.90 | 3,500 | $104,650 | 814,679 |
| 2026-05-15 11:01 | 2026-05-14 | HROW | HARROW, INC. | BAUM MARK L | Director, Officer | BUY | $30.20 | 10,000 | $302,000 | 2,996,130 |
| 2026-05-14 20:05 | 2026-05-13 | DYN | Dyne Therapeutics, Inc. | Friedl-Naderer Johanna | Officer | SELL | $18.36 | 228 | $4,186 | 154,353 |
| 2026-05-14 20:10 | 2026-05-12 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Bozic Carmen | Officer | SELL | $450.00 | 6,988 | $3,144,600 | 26,088 |
| 2026-05-14 20:10 | 2026-05-12 | LTRN | Lantern Pharma Inc. | Schalop Lee Troy | Director | BUY | $2.06 | 48,544 | $100,001 | 48,544 |
| 2026-05-14 20:05 | 2026-05-12 | SLGL | Sol-Gel Technologies Ltd. | Opaleye Management Inc. | 10% owner | BUY | $67.36 | 3,437 | $231,502 | 488,437 |
| 2026-05-14 20:10 | 2026-05-12 | LTRN | Lantern Pharma Inc. | KEYSER D JEFFREY | Director | BUY | $2.06 | 48,544 | $100,001 | 94,303 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Pharmaceutical Preparations sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (2834) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Pharmaceutical Preparations
Every transaction in the Pharmaceutical Preparations industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.